Education
About Us
Working with TipRanks
Follow Us
Arkema (FR:AKE)
:AKE
AKE Analyst Ratings
Moderate Buy
7 Buy
1 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AKE Stock 12 Month Forecast
Average Price Target
€91.94
▲(49.86% Upside)
| Highest Price Target€105.00 | Average Price Target€91.94 | Lowest Price Target€67.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Citi
Reiterated
04/14/25
Goldman Sachs
Reiterated
04/11/25
Deutsche Bank
Reiterated
04/09/25
J.P. Morgan
Downgraded
03/27/25
Berenberg Bank
Reiterated
03/10/25
Jefferies
Reiterated
03/03/25
Kepler Capital
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/27/25
Barclays
€107.01→€102.66
Buy
67.33%
Upside
Reiterated
11/27/24
Barclays Reaffirms Their Buy Rating on Arkema (0IB0)
Morgan Stanley
€104
Buy
69.52%
Upside
Upgraded
09/05/24
We would expect management not to guide to the current consensus '25 EBITDA growth of c10% at the FY results, we judge that the shares are currently pricing in c2% growth. While the macro environment remains challenging now, we see Arkema's growth backed by project expansion which increases our confidence on delivery. Further the arrival of a falling rate environment could improve prospects. Further robust FCF generation could see management consider all-routes to value realization, including capital returns.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
Reiterated
04/14/25
Goldman Sachs
Reiterated
04/11/25
Deutsche Bank
Reiterated
04/09/25
J.P. Morgan
Downgraded
03/27/25
Berenberg Bank
Reiterated
03/10/25
Jefferies
Reiterated
03/03/25
Kepler Capital
Reiterated
02/27/25
Stifel Nicolaus
Reiterated
02/27/25
Barclays
€107.01→€102.66
Buy
67.33%
Upside
Reiterated
11/27/24
Barclays Reaffirms Their Buy Rating on Arkema (0IB0)
Morgan Stanley
€104
Buy
69.52%
Upside
Upgraded
09/05/24
We would expect management not to guide to the current consensus '25 EBITDA growth of c10% at the FY results, we judge that the shares are currently pricing in c2% growth. While the macro environment remains challenging now, we see Arkema's growth backed by project expansion which increases our confidence on delivery. Further the arrival of a falling rate environment could improve prospects. Further robust FCF generation could see management consider all-routes to value realization, including capital returns.
Best Analysts Covering Arkema
Which Analyst Should I Follow If I Want to Buy FR:AKE and Sell After:
1 Month
xxx
Success Rate
10/20 ratings generated profit
Average Return
-1.24%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -1.24% per trade.
3 Months
xxx
Success Rate
16/31 ratings generated profit
Average Return
+1.02%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.61% of your transactions generating a profit, with an average return of +1.02% per trade.
1 Year
Success Rate
18/31 ratings generated profit
Average Return
+2.55%
reiterated a buy rating 14 days ago
Copying Virginie Boucher-Ferte's trades and holding each position for 1 Year would result in 58.06% of your transactions generating a profit, with an average return of +2.55% per trade.
2 Years
xxx
Success Rate
15/31 ratings generated profit
Average Return
+9.77%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 48.39% of your transactions generating a profit, with an average return of +9.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AKE Analyst Recommendation Trends
Rating
Nov 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
2
1
1
0
1
Buy
7
7
7
9
8
Hold
1
0
0
0
1
Sell
0
0
0
1
1
Strong Sell
0
0
0
0
0
total
10
8
8
10
11
Each month's total comprises the sum of three months' worth of ratings.
AKE Financial Forecast
AKE Stock Forecast FAQ
What is FR:AKE’s average 12-month price target, according to analysts?
Based on analyst ratings, Arkema’s 12-month average price target is 91.94.
What is FR:AKE’s upside potential, based on the analysts’ average price target?
Arkema has 49.86% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Arkema a Buy, Sell or Hold?
Arkema has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 1 hold ratings and 1 sell ratings.
What is Arkema’s share price target?
The average share price target for Arkema is 91.94. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €105.00 ,and the lowest forecast is €67.00. The average share price target represents 49.86% Increase from the current price of €61.35.
The highest analyst share price target is €105.00 ,and the lowest forecast is €67.00. The average share price target represents 49.86% Increase from the current price of €61.35.
What do analysts say about Arkema?
Arkema’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of Arkema?
To buy shares of FR:AKE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.